$0.165
-0.001 (-0.42%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Vistagen Therapeutics Inc (VTGN) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting VTGN is Strong sell.
Vistagen Therapeutics Inc (VTGN) 20-Day simple moving average is 0.19, while Vistagen Therapeutics Inc (VTGN) share price is $—, making it Sell.
Vistagen Therapeutics Inc (VTGN) 60-Day simple moving average is 0.23, while Vistagen Therapeutics Inc (VTGN) share price is $—, making it Sell.
Technical Analysis for VTGN
AI Technical VTGNAs of 2026-11-07, the technical board for Vistagen Therapeutics Inc (VTGN) reads strong sell: 1 indicators are flashing buy, 9 are indicating sell, and 3 are neutral. Price at $0.16 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 33.351, MACD stands at -0.0204 (Sell), Stochastic %K stands at 11.935 (Buy), Stochastic %D stands at 13.491 and CCI stands at -77.022.
VTGN trades below the 60-day SMA (0.23) and below the 200-day SMA (0.43). Immediate resistance sits at Classic R1 0.18, then R2 0.20. Support sits at Classic S1 0.16, then S2 0.15.
Vistagen Therapeutics Inc (VTGN) Support & Resistance Level
Vistagen Therapeutics Inc (VTGN) Technical Indicators
2026-11-07
| Name | Value |
|---|---|
| RSI_14 | 33.351 |
| STOCHk_14_3_3 | 11.935 |
| STOCHd_14_3_3 | 13.491 |
| CCI_20 | -77.022 |
| AO_5_34 | -0.057 |
| MOM_10 | -0.016 |
| MACD_12_26_9 | -0.020 |
Vistagen Therapeutics Inc (VTGN) Relative Strength Index (RSI_14) is 33.351, creating a Neutral signal.
Vistagen Therapeutics Inc (VTGN) Stochastic %K is 11.935, creating a Buy signal.
Vistagen Therapeutics Inc (VTGN) Stochastic %D is 13.491, creating a Buy signal.
Vistagen Therapeutics Inc (VTGN) CCI_20 is -77.022, creating a Neutral signal.
Vistagen Therapeutics Inc (VTGN) Awesome Oscillator (AO) is -0.057, creating a Sell signal.
Vistagen Therapeutics Inc (VTGN) Momentum (MOM) is -0.016, creating a Sell signal.
Vistagen Therapeutics Inc (VTGN) Moving Average Convergence Divergence (MACD) is -0.020, creating a Sell signal.
Vistagen Therapeutics Inc (VTGN) Moving Average
2026-11-07
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 0.170 | Sell |
| MA_10 | 0.171 | Sell |
| MA_20 | 0.186 | Sell |
| MA_60 | 0.233 | Sell |
| MA_200 | 0.433 | Sell |
| MA_250 | 0.861 | Sell |
Vistagen Therapeutics Inc (VTGN) 5-Day simple moving average is 0.170, while Vistagen Therapeutics Inc (VTGN) share price is $, making it a Sell.
Vistagen Therapeutics Inc (VTGN) 10-Day simple moving average is 0.171, while Vistagen Therapeutics Inc (VTGN) share price is $, making it a Sell.
Vistagen Therapeutics Inc (VTGN) 20-Day simple moving average is 0.186, while Vistagen Therapeutics Inc (VTGN) share price is $, making it a Sell.
Vistagen Therapeutics Inc (VTGN) 60-Day simple moving average is 0.233, while Vistagen Therapeutics Inc (VTGN) share price is $, making it a Sell.
Vistagen Therapeutics Inc (VTGN) 200-Day simple moving average is 0.433, while Vistagen Therapeutics Inc (VTGN) share price is $, making it a Sell.
Vistagen Therapeutics Inc (VTGN) 250-Day simple moving average is 0.861, while Vistagen Therapeutics Inc (VTGN) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.